Your browser doesn't support javascript.
loading
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.
Nishida, Yoshihiro; Urakawa, Hiroshi; Nakayama, Robert; Kobayashi, Eisuke; Ozaki, Toshifumi; Ae, Keisuke; Matsumoto, Yoshihiro; Tsuchiya, Hiroyuki; Goto, Takahiro; Hiraga, Hiroaki; Naka, Norifumi; Takahashi, Shunji; Ando, Yuichi; Ando, Masahiko; Kuwatsuka, Yachiyo; Hamada, Shunsuke; Ueda, Takafumi; Kawai, Akira.
Affiliation
  • Nishida Y; Department of Orthopaedic Surgery, Nagoya University, Nagoya, Japan.
  • Urakawa H; Department of Rehabilitation, Nagoya University Hospital, Nagoya, Japan.
  • Nakayama R; Department of Orthopaedic Surgery, Nagoya University, Nagoya, Japan.
  • Kobayashi E; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Ozaki T; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Ae K; Department of Musculoskeletal Oncology, National Cancer Center, Tokyo, Japan.
  • Matsumoto Y; Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Tsuchiya H; Department of Orthopaedic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Goto T; Department of Orthopaedic Surgery, Kyushu University, Fukuoka, Japan.
  • Hiraga H; Department of Orthopaedic Surgery, Kanazawa University, Kanazawa, Japan.
  • Naka N; Department of Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Takahashi S; Department of Orthopaedic Surgery, Hokkaido Cancer Center, Sapporo, Japan.
  • Ando Y; Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
  • Ando M; Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan.
  • Kuwatsuka Y; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Hamada S; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Ueda T; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Kawai A; Department of Orthopaedic Surgery, Aichi Cancer Hospital, Nagoya, Japan.
Int J Cancer ; 148(1): 140-149, 2021 01 01.
Article in En | MEDLINE | ID: mdl-32638374
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Neurofibrosarcoma / Protein Kinase Inhibitors / Indazoles / Neutropenia Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Neurofibrosarcoma / Protein Kinase Inhibitors / Indazoles / Neutropenia Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2021 Type: Article Affiliation country: Japan